Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,961,247
-
Share change
-
+835,185
-
Total reported value
-
$10,865,226
-
Price per share
-
$3.67
-
Number of holders
-
27
-
Value change
-
+$3,024,213
-
Number of buys
-
13
-
Number of sells
-
6
Institutional Holders of MOLECULIN BIOTECH INC - COM (MBRX) as of Q2 2021
As of 30 Jun 2021,
MOLECULIN BIOTECH INC - COM (MBRX) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,961,247 shares.
The largest 10 holders included
VANGUARD GROUP INC, Sio Capital Management, LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, NORTHERN TRUST CORP, CITADEL ADVISORS LLC, XTX Topco Ltd, SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC, and GSA CAPITAL PARTNERS LLP.
This page lists
27
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.